Juvisé Pharmaceuticals' portfolio has been built through the acquisition of princeps drugs from large pharmaceutical companies. We focus on essential medicines, recognized by the medical community for their therapeutic value, and we ensure their production, marketing and promotion to health professionals. In doing so, each year we contribute to improving the health of around 2.5 million patients around the world.